Literature DB >> 8137744

Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.

A Nishimura1, T Shinki, C H Jin, Y Ohyama, M Noshiro, K Okuda, T Suda.   

Abstract

We have reported that PTH inhibits 25-hydroxyvitamin D3-24-hydroxylase messenger RNA (mRNA) expression induced by 1 alpha,25-dihydroxyvitamin D3 [1 alpha, 25-(OH)2D3] in rat kidney but not intestine. In the present study, we examined whether the suppression of 24-hydroxylase mRNA expression by PTH occurs commonly in tissues and cells which have PTH receptors. Administration of 1 alpha, 25-(OH)2D3 into rats fed a synthetic vitamin D-repleted diet containing adequate calcium greatly increased serum levels of calcium and 1 alpha, 25-(OH)2D3. Also, there was a 4-fold increase in bone 24-hydroxylase activity in response to 1 alpha, 25-(OH)2D3 administration. In rats fed a low calcium diet, renal 24-hydroxylase activity was suppressed probably due to secondary hyperparathyroidism. In contrast, the low calcium feeding did not suppress bone 24-hydroxylase activity. The expression of 24-hydroxylase mRNA in rat osteoblastic C-26 and C-11 cells was similar and attained maximal levels 24 h after cells were incubated with 10(-8) M 1 alpha, 25-(OH)2D3. Induction of 24-hydroxylase mRNA expression by 1 alpha, 25-(OH)2D3 was much greater and earlier in immature C-26 cells than mature C-11 cells. Simultaneous addition of PTH, prostaglandin E2, or cAMP together with 1 alpha, 25-(OH)2D3 did not down-regulate mRNA expression of 24-hydroxylase induced by the vitamin in both C-26 and C-11 cells. Of the three osteoblastic cells (C-26, C-20, and C-11) examined, C-26 cells showed the least mRNA expression of vitamin D receptors, in spite of the highest expression of 24-hydroxylase mRNA. These results suggest that unlike in the kidney, bone 24-hydroxylase mRNA expression is not down-regulated by PTH despite of the presence of PTH receptors. They also suggest that the degree of the induction of 24-hydroxylase mRNA by 1 alpha, 25-(OH)2D3 is not explained simply by the vitamin D receptors content.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137744     DOI: 10.1210/endo.134.4.8137744

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus.

Authors:  Mahmoud M Kamel; Shawky A Fouad; Omina Salaheldin; Abd El-Rahman A Abd El-Razek; Abeer I Abd El-Fatah
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

Review 3.  Vitamin D: newly discovered actions require reconsideration of physiologic requirements.

Authors:  Daniel D Bikle
Journal:  Trends Endocrinol Metab       Date:  2010-02-10       Impact factor: 12.015

4.  Effects of 24,25(OH)2D3, 1,25(OH)2D3 and 25(OH)D3 on alkaline and tartrate-resistant acid phosphatase activities in fetal rat calvaria.

Authors:  M J Municio; M L Traba
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

5.  Vitamin D metabolism: new concepts and clinical implications.

Authors:  P H Anderson; B K May; H A Morris
Journal:  Clin Biochem Rev       Date:  2003

6.  A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.

Authors:  Martin Kaufmann; Seong Min Lee; J Wesley Pike; Glenville Jones
Journal:  Endocrinology       Date:  2015-10-06       Impact factor: 4.736

7.  Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3.

Authors:  Izuru Kurahashi; Ayako Matsunuma; Tetsuya Kawane; Masatoshi Abe; Noboru Horiuchi
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

8.  Determinants of Plasma 25-Hydroxyvitamin D Concentrations among Breast Cancer Survivors in Korea.

Authors:  Woo-Kyoung Shin; Zisun Kim; Hyun Jo Youn; Jihyoung Cho; Jung Eun Lee
Journal:  Nutrients       Date:  2018-03-20       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.